EF Hutton Initiates Coverage On Anixa Biosciences With Buy Rating, Announces Price Target of $10
EF Hutton Initiates Coverage On Anixa Biosciences With Buy Rating, Announces Price Target of $10
EF Hutton發佈對anixa biosciences的買入評級,宣佈目標價格爲10美元。
EF Hutton analyst Jason Kolbert initiates coverage on Anixa Biosciences (NASDAQ:ANIX) with a Buy rating and announces Price Target of $10.
EF Hutton分析師Jason Kolbert發佈對納斯達克ANIX的anixa biosciences的買入評級,並宣佈價格目標爲10美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。